Drug Interactions Database

944 interactions from BNF 85 - Check your medicines

Source: BNF 85

Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916

grapefruitjuice elexacaftor

increases exposure

Severe Theoretical

grapefruitjuice eliglustat

increases exposure

Severe Theoretical

grapefruitjuice encorafenib

increases exposure

Severe Study

grapefruitjuice everolimus

increases exposure

Severe Theoretical

grapefruitjuice felodipine

increases exposure

Severe Study

grapefruitjuice guanfacine

increases exposure

Severe Theoretical

grapefruitjuice ibrutinib

increases exposure

Severe Theoretical

grapefruitjuice ivabradine

increases exposure

Severe Study

grapefruitjuice ivacaftor

increases exposure

Severe Theoretical

grapefruitjuice lapatinib

increases exposure

Severe Theoretical

grapefruitjuice larotrectinib

increases exposure

Severe Theoretical

grapefruitjuice lercanidipine

increases exposure

Severe Theoretical

grapefruitjuice lomitapide

increases exposure

Severe Theoretical

grapefruitjuice lorlatinib

increases concentration

Severe Theoretical

grapefruitjuice lurasidone

increases exposure

Severe Theoretical

grapefruitjuice naloxegol

increases exposure

Severe Theoretical

grapefruitjuice neratinib

increases exposure

Severe Theoretical

grapefruitjuice nifedipine

increases exposure

Severe Study

grapefruitjuice nilotinib

increases exposure

Severe Theoretical

grapefruitjuice olaparib

increases exposure

Severe Theoretical

grapefruitjuice oralbudesonide

increases exposure

Severe Study

grapefruitjuice oralcorticosteroids

increases exposure

Severe Study

grapefruitjuice palbociclib

increases exposure

Severe Theoretical

grapefruitjuice pazopanib

increases exposure

Severe Theoretical

grapefruitjuice pimozide

increases exposure

Severe Theoretical

grapefruitjuice piperaquine

increases concentration

Severe Theoretical

grapefruitjuice pralsetinib

increases exposure

Severe Study

grapefruitjuice quetiapine

increases exposure

Severe Theoretical

grapefruitjuice ranolazine

increases concentration

Severe Theoretical

grapefruitjuice regorafenib

increases exposure

Severe Theoretical

grapefruitjuice ribociclib

increases exposure

Severe Theoretical

grapefruitjuice ripretinib

increases exposure

Severe Theoretical

grapefruitjuice rupatadine

increases exposure

Severe Study

grapefruitjuice selumetinib

increases exposure

Severe Theoretical

grapefruitjuice sertraline

increases exposure

Severe Study

grapefruitjuice sunitinib

increases exposure

Severe Theoretical

grapefruitjuice tacrolimus

increases concentration

Severe Study

grapefruitjuice tezacaftor

increases exposure

Severe Study

grapefruitjuice tolvaptan

increases exposure

Severe Study

grapefruitjuice venetoclax

increases exposure

Severe Theoretical

grapefruitjuice verapamil

increases exposure

Severe Study

grapefruitjuicevery amlodipine

increases exposure

Severe Study

grapefruitjuicevery calciumchannelblockers

increases exposure

Severe Study

haloperidol antiepileptics

increases risk of overheatinganddehydration

Severe Theoretical

haloperidol dopaminereceptoragonists

decreases effects

Severe Theoretical

haloperidol zonisamide

increases risk of overheatinganddehydration

Severe Theoretical

hiv-proteaseinhibitors clopidogrel

decreases efficacy

Severe Theoretical

hiv-proteaseinhibitors ergometrine

increases risk of ergotism

Severe Theoretical

hiv-proteaseinhibitors ergotamine

increases risk of ergotism

Severe Theoretical

hiv-proteaseinhibitors irinotecan

increases risk of toxicity

Severe Study

Prev 1 ... 6 7 8 9 10 ... 19 Next

944 interactions

Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.